Alere i FluA*B Biologic Test Relocated in Emergency Service for Flu Diagnosis

It appears that the heavyness of flu pathology, the diagnosis limits and the validity of it was well studied in the last years.However, the economical impact and the organisation benefit in emergency service is not yet evaluated Our purpose is to study the impact of implementation of fast flu diagnosis by molecular biology available in emergency service in the economic field .

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Flu Infections Influenza, Human Orthomyxoviridae Infections RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Groupe Hospitalier Paris Saint Joseph

Paris, Île-de-France Region, 75014, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

respiratory symptoms
fever >38°C
general symptoms of flu like pathology

Exclusion criteria

cognitive disorders
patient with guardianship
patient already having a flu diagnosis in the last 7 days
without social protection.

Treatment and study plan

Test A i Flu A&B implemented in emergency service

Diagnostic Test

Test A i Flu A&B implemented in emergency service

Primary outcomes

time to have the result of the biological test

Time frame: 3 hours

Sponsors and collaborators

Lead sponsor

Fondation Hôpital Saint-Joseph

Other

Registry information

Important dates

Study start: 2016
Primary completion: 2016
Study completion: 2018
First posted: Sep 26, 2017
Registry last updated: Aug 9, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed